State aid: Commission approves €50 million Italian support scheme for production and supply of medical equipment and masks during Coronavirus outbreak
The European Commission has approved a €50 million Italian aid scheme to support the production and supply of medical devices, such as ventilators, and personal protection equipment, such as masks, goggles, gowns, and safety suits. The scheme will help Italy provide the necessary medical treatment to those infected, while protecting healthcare operators and citizens. The scheme was approved under the State aid Temporary Framework to support the economy in the context of the COVID-19 outbreak adopted by the Commission on 19 March 2020. The Commission approved the scheme within 48 hours from receiving the notification from Italy.
Executive Vice President Margrethe Vestager, in charge of competition policy, yesterday said:
"These are very difficult times, especially in Italy. We have to do what we can to mitigate the impact of the Coronavirus outbreak on human lives and livelihoods. The Italian scheme approved today, shortly after the adoption of our new State aid Temporary Framework, will support companies ready to produce and supply medical equipment and masks. These are needed urgently. We will continue to work with Member States to ensure timely, coordinated and effective action.”
The Italian support measures
Italy notified to the Commission a €50 million support scheme for the production and supply of medical devices and personal protection equipment under the Temporary Framework.
The scheme aims at increasing the market output of such devices and protection equipment, which has proven to be insufficient as a result of the peak in demand arising from the Coronavirus outbreak.
Under the scheme, financial support will be available to companies of all sizes which (i) set up new facilities for the production of medical devices and personal protection equipment; (ii) expand the production of their existing structures producing such equipment; or (iii) convert their production line to that effect. The beneficiaries of the support will make the products available to the Italian authorities at the market prices applied in December 2019, i.e. prior to the outbreak in Italy.
The aid will take the form of direct grants or repayable advances. The repayable grants will be converted into direct grants, if the beneficiaries supply the equipment and devices in an expedited manner to the Italian authorities.
The scheme will ensure swift and adequate support to companies ready to produce and supply medical devices and personal protection equipment and will incentivise rapid production and timely delivery of these essential products.
The Commission found that the Italian measure is in line with the conditions set out in the Temporary Framework for aid in the form of direct grants and repayable advances. In particular, under the scheme, the support will not exceed €800 000 per company as foreseen by the Temporary Framework.
The Commission concluded that the measure is necessary, appropriate and proportionate to remedy a serious disturbance in the economy of a Member State, in line with Article 107(3)(b) TFEU and the conditions set out in the Temporary Framework.
On this basis, the Commission approved the measures under EU State aid rules.
Latest News from
COVID-19: EU adopts slot waiver to help airlines31/03/2020 16:43:00
The EU will suspend until 24 October 2020 the airport slot requirements which oblige airlines to use at least 80% of their take-off and landing slots in order to keep them the following year.
Statement by the European Commission following the first meeting of the EU-UK Joint Committee31/03/2020 15:25:00
The European Union and the United Kingdom yesterday held their first Joint Committee meeting on the implementation and application of the Withdrawal Agreement, by means of teleconference.
Coronavirus: Commission presents practical guidance to ensure the free movement of critical workers31/03/2020 14:51:00
The Commission yesterday issued new practical advice to ensure that mobile workers within the EU, in particular those in critical occupations to fight the coronavirus pandemic, can reach their workplace.
EU mobilises immediate support for its Western Balkan partners to tackle coronavirus31/03/2020 13:25:00
As part of theglobal response to the coronavirus outbreak, the European Commission has announced up to €38 million in immediate support for the Western Balkans to tackle the health emergency caused by coronavirus and reallocation of €374 million to help the socio-economic recovery of the region.
EU research funds to fight the coronavirus31/03/2020 12:38:00
As the world struggles to contain the coronavirus pandemic, the EU is supporting efforts to develop vaccines and effective treatments as soon as possible.
Disinformation: how to recognise and tackle Covid-19 myths31/03/2020 11:33:00
The outbreak of the coronavirus has led to disinformation that hampers efforts to contain the pandemic. Read on to find out what you can do.
Chemical hazards data and modelling boost31/03/2020 09:25:00
EFSA has updated its OpenFoodTox database which now includes toxicity data on almost 5,000 chemicals drawn from over 2,000 scientific evaluations carried out by EFSA since 2002.
Statement from Commission President von der Leyen on proposals to fight the economic effects of the coronavirus crisis30/03/2020 16:43:00
The European Council tasked the Eurogroup to come up with proposals within the next weeks.
Russia: Declaration by the High Representative on behalf of the EU on listing the European Endowment for Democracy as an “undesirable organisation”30/03/2020 15:25:00
The EU rejects the decision by the Russian authorities to include the European Endowment for Democracy (EED) on their list of “undesirable organisations”.
ESMA Issues Guidance on Financial Reporting Deadlines in Light of Covid-1930/03/2020 13:25:00
The European Securities and Markets Authority (ESMA), the EU’s securities markets regulator, has issued a Public Statement on the implications of the COVID-19 pandemic on the deadlines for publishing financial reports which apply to listed issuers under the Transparency Directive.